For some users, they can even help drop blood sugar levels below traditional A1C targets and into the nondiabetic range. Health experts don’t use the word “reversal” for type 2 diabetes. They tend to ...

GLP-1 users have a higher risk of non-scarring alopecia, a nonpermanent type of hair loss, compared to non-GLP-1 users, a new study suggests.

In patients with type 2 diabetes inadequately controlled with metformin, adding a novel nonpeptide oral GLP-1 receptor agonist to metformin boosts glycemic control.

Meaghan is an editor and writer who also has experience practicing holistic medicine as an acupuncturist and herbalist. She's passionate about helping individuals live full, healthy and happy lives at ...

GLP-1 drugs like Ozempic work across multiple body systems including the brain and the pancreas to help drive weight loss and ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

Medicare patients are getting access to GLP-1s for obesity through the Bridge program. But questions linger regarding ...

The trial follows earlier signs that GLP-1s can reduce symptoms of alcohol and drug addiction similarly to how they reduce ...

As Americans are encouraged to go direct with weight-loss drug prescriptions, retail pharmacy chains are poised to win big.

If a GLP-1 can change one brain this much, what happens when it changes 40 million? An evidence-based tour of America by 2030 ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...